SILVER POINT CAPITAL L.P. purchased 1.5% of their position (68K shares) of KEENOVA THERAPEUTICS PLC on the open market
Open‑market purchase worth $6.04M — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/19/2025ACC: 0001193125-25-288480
10% Owner
Since Nov 2025
+68K
Net shares
Net buyer
$6.04M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
68K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+26K
Price / share
$88.88
Trade value
$2.31M
% of position
0.6%
11/17/2025
4.50M→4.53M
Common Stock
Direct
Shares
+42K
Price / share
$88.88
Trade value
$3.73M
% of position
0.9%
11/19/2025
4.53M→4.57M
Total
Net shares
+68K
Net value
$6.04M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2025 | P · Purchase | +26K | $88.88 | $2.31M | 0.6% | 4.50M | 4.53M |
| Common Stock Direct | 11/19/2025 | P · Purchase | +42K | $88.88 | $3.73M | 0.9% | 4.53M | 4.57M |
| Total | +68K | $6.04M | ||||||
Derivative Transactions0
No derivative transactions reported